NATURAL ALTERNATIVES INTERNATIONAL INC Treasury Stock, Common, Shares
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) had Treasury Stock, Common, Shares of 3.37 million shares as of 2026-03-31, per its 10-Q filed 2026-05-19.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure
us-gaap:TreasuryStockCommonShares · last filed 2026-05-19
- 2026-03-31: Treasury Stock, Common, Shares 3.37M shares.
- 2025-12-31: Treasury Stock, Common, Shares 3.33M shares.
- 2025-09-30: Treasury Stock, Common, Shares 3.33M shares.
- 2025-06-30: Treasury Stock, Common, Shares 3.33M shares.
| Period end | Treasury Stock, Common, Shares |
|---|---|
| 2026-03-31 | 3.37M shares 10-Q · filed 2026-05-19 |
| 2025-12-31 | 3.33M shares 10-Q · filed 2026-02-13 |
| 2025-09-30 | 3.33M shares 10-Q · filed 2025-11-12 |
| 2025-06-30 | 3.33M shares 10-Q · filed 2026-05-19 |
| 2025-03-31 | 3.33M shares 10-Q · filed 2025-05-14 |
| 2024-12-31 | 3.28M shares 10-Q · filed 2025-02-14 |
| 2024-09-30 | 3.28M shares 10-Q · filed 2024-11-13 |
| 2024-06-30 | 3.28M shares 10-K · filed 2025-09-23 |
| 2024-03-31 | 3.28M shares 10-Q · filed 2024-05-14 |
| 2023-12-31 | 3.24M shares 10-Q · filed 2024-02-13 |
| 2023-09-30 | 3.24M shares 10-Q · filed 2023-11-09 |
| 2023-06-30 | 3.24M shares 10-K · filed 2024-09-27 |
| 2023-03-31 | 3.23M shares 10-Q · filed 2023-05-15 |
| 2022-06-30 | 3.06M shares 10-K · filed 2023-09-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANNATECH INC (MTEX) | United States | $0.014B | |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |